About TSH
Vision
Pipeline
Collaboration
Corporate Video
Organization
History
Parent Company
News
Products
Prescription medication
Cardiovascular
Central Nervous
Gastrointestinal
Others
Patient Care
Overall
AlphaLiquidⓇ100
CellMax DNA Genetic Cancer Risk
CelleMax LBx Liquid Biopsy
CelleMax LBx NCCN LUNG
CellMax TBx Tissue Biopsy
MPapⓇ test
Report Query
Investors
Institutional Investor Conference
Financials
Monthly Revenues
Financial Reports
Annual Reports
Shareholder Serivces
Dividends
Shareholders' Meeting
List of Major Shareholders
Corporate Governance
Board of Directors
Audit Committee
Remuneration Committee
Major Internal Policies
Internal Audit
Careers
Learnings and Development
Join TSH
CSR
CSR Promotion Center
Social Participation
Stakeholder
Report Query
Search
繁
EN
Home
Investors
Institutional Investor Conference
Financial Reports
Menu
Investors
Institutional Investor Conference
Institutional Investor Conference
Financial Reports
Monthly Revenues
Financials
Annual Reports
Shareholder Serivces
Dividends
Shareholders Meeting
List of Major Shareholders
Corporate Governance
Board of Directors
Audit Committee
Remuneration Committee
Major Internal Policies
Internal Audit
Financial Reports
2021
2020
2019
2018
TSH 2021Q3 Financial Report
TSH 2021Q2 Financial Report
TSH 2021Q1 Financial Report
TSH 2020Q4 Financial Report
TSH 2020Q3 Financial Report
2020Q2 Financial Report
TSH 2020Q1 Financial Report
TSH 2019Q4 Financial Report
TSH 2019Q3 Financial Report
TSH 2019Q2 Financial Report
TSH 2019Q1 Financial Report
TSH 2018Q4 Financial Report
TSH 2018Q3 Financial Report
TSH 2018Q2 Financial Report
TSH 2018Q1 Financial Report
